Proposal to amend Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices - Related Opinions

The EESC:

• welcomes this package of measures;
• recognises that need to pay particular attention to the situation of smaller EU Member States, Cyprus, Ireland and Malta in particula;
• stresses in particular the central role of a functioning, fair and efficient internal market;
• welcomes the packaging requirements for UK products included in the package;
• draws attention to the need for a timely and sustainable solution, which should be developed within the framework of the European Pharmaceutical Strategy.